Progress and Challenges in the Development of COVID-19 Vaccines and Current Understanding of SARS-CoV-2-Specific Immune Responses

被引:12
|
作者
Kim, Kyun-Do [1 ]
Hwang, Insu [1 ]
Ku, Keun Bon [1 ]
Lee, Sumin [1 ]
Kim, Seong-Jun [1 ]
Kim, Chonsaeng [1 ]
机构
[1] Korea Res Inst Chem Technol, Ctr Convergent Res Emerging Virus Infect, Daejeon 34114, South Korea
关键词
COVID-19; SARS-CoV-2; Coronavirus; vaccine; immune response; RESPIRATORY-SYNDROME-CORONAVIRUS; NEUTRALIZING ANTIBODIES; INFLAMMATORY CYTOKINES; SARS; ACTIVATION; RECEPTORS; INFECTION; SPIKE; INTERFERON; EXPRESSION;
D O I
10.4014/jmb.2006.06006
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The outbreak of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is spreading globally, and the WHO has declared this outbreak a pandemic. Vaccines are an effective way to prevent the rapid spread of COVID-19. Furthermore, the immune response against SARS-CoV-2 infection needs to be understood for the development of an efficient and safe vaccine. Here, we review the current understanding of vaccine targets and the status of vaccine development for COVID-19. We also describe host immune responses to highly pathogenic human coronaviruses in terms of innate and adaptive immunities.
引用
收藏
页码:1109 / 1115
页数:7
相关论文
共 50 条
  • [21] Duration of post-COVID-19 symptoms is associated with sustained SARS-CoV-2-specific immune responses
    Files, Jacob K.
    Sarkar, Sanghita
    Fram, Tim R.
    Boppana, Sushma
    Sterrett, Sarah
    Qin, Kai
    Bansal, Anju
    Long, Dustin M.
    Sabbaj, Steffanie
    Kobie, James J.
    Goepfert, Paul A.
    Erdmann, Nathan
    JCI INSIGHT, 2021, 6 (15)
  • [22] SARS-CoV-2-Specific Adaptive Immunity in COVID-19 Survivors With Asthma
    Chen, Li
    Yue, Junqing
    Zhang, Shengding
    Bai, Wenxue
    Qin, Lu
    Zhang, Cong
    Wu, Bihao
    Li, Moxuan
    Xu, Shuyun
    Jiang, Qing
    Yang, Lin
    Xu, Qingxiu
    Zhu, Rongfei
    Xie, Min
    Gong, Rui
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [23] SARS-CoV-2 variants and COVID-19 vaccines: Current challenges and future strategies
    Gong, Wenping
    Parkkila, Seppo
    Wu, Xueqiong
    Aspatwar, Ashok
    INTERNATIONAL REVIEWS OF IMMUNOLOGY, 2023, 42 (06) : 393 - 414
  • [24] Research and resource needs for understanding host immune responses to SARS-CoV-2 and COVID-19 vaccines during aging
    Mercy PrabhuDas
    Rebecca Fuldner
    Donna Farber
    George A. Kuchel
    Joan Mannick
    Janko Nikolich-Zugich
    Ranjan Sen
    Joanne Turner
    Nature Aging, 2021, 1 : 1073 - 1077
  • [25] Research and resource needs for understanding host immune responses to SARS-CoV-2 and COVID-19 vaccines during aging
    PrabhuDas, Mercy
    Fuldner, Rebecca
    Farber, Donna
    Kuchel, George A.
    Mannick, Joan
    Nikolich-Zugich, Janko
    Sen, Ranjan
    Turner, Joanne
    NATURE AGING, 2021, 1 (12): : 1073 - 1077
  • [26] A comparative characterization of SARS-CoV-2-specific T cells induced by mRNA or inactive virus COVID-19 vaccines
    Lim, Joey Ming Er
    Hang, Shou Kit
    Hariharaputran, Smrithi
    Chia, Adeline
    Tan, Nicole
    Lee, Eng Sing
    Chng, Edwin
    Lim, Poh Lian
    Young, Barnaby E.
    Lye, David Chien
    Le Bert, Nina
    Bertoletti, Antonio
    Tan, Anthony T.
    CELL REPORTS MEDICINE, 2022, 3 (11)
  • [27] SARS-CoV-2-specific immune response in COVID-19 convalescent individuals (vol 6, 256, 2021)
    Pan, Yunbao
    Jiang, Xianghu
    Yang, Liu
    Chen, Liangjun
    Zeng, Xiaojiao
    Liu, Guohong
    Tang, Yueting
    Qian, Chungen
    Wang, Xinming
    Cheng, Fangming
    Lin, Jun
    Wang, Xinghuan
    Li, Yirong
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2021, 6 (01)
  • [28] SARS-CoV-2-specific antibody rearrangements in prepandemic immune repertoires of risk cohorts and patients with COVID-19
    Paschold, Lisa
    Simnica, Donjete
    Willscher, Edith
    Vehreschild, Maria J. G. T.
    Dutzmann, Jochen
    Sedding, Daniel G.
    Schultheiss, Christoph
    Binder, Mascha
    JOURNAL OF CLINICAL INVESTIGATION, 2021, 131 (01):
  • [29] SARS-CoV-2-specific T cells in the changing landscape of the COVID-19 pandemic
    Bertoletti, Antonio
    Le Bert, Nina
    Tan, Anthony T.
    IMMUNITY, 2022, 55 (10) : 1764 - 1778
  • [30] Distinct features of SARS-CoV-2-specific IgA response in COVID-19 patients
    Yu, Hai-qiong
    Sun, Bao-qing
    Fang, Zhang-fu
    Zhao, Jin-cun
    Liu, Xiao-yu
    Li, Yi-min
    Sun, Xi-zhuo
    Liang, Hong-feng
    Zhong, Bei
    Huang, Zhi-feng
    Zheng, Pei-yan
    Tian, Li-feng
    Qu, Hui-qi
    Liu, De-chen
    Wang, Er-yi
    Xiao, Xiao-jun
    Li, Shi-yue
    Ye, Feng
    Guan, Li
    Hu, Dong-sheng
    Hakonarson, Hakon
    Liu, Zhi-gang
    Zhong, Nan-shan
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56 (02)